➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Express Scripts
AstraZeneca
Harvard Business School
Merck

Last Updated: March 2, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DESIPRAMINE HYDROCHLORIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Desipramine Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000202 Buprenorphine Maintenance for Opioid Addicts - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 1988-08-01 The purpose of this study is to evaluate the efficacy of buprenorphine and desipramine in treatment of opiate and cocaine dependence.
NCT00000202 Buprenorphine Maintenance for Opioid Addicts - 1 Completed Yale University Phase 2 1988-08-01 The purpose of this study is to evaluate the efficacy of buprenorphine and desipramine in treatment of opiate and cocaine dependence.
NCT00000212 IV Cocaine Abuse: A Laboratory Model - 1 Completed Columbia University Phase 2 1987-07-01 The purpose of this study is to evaluate the effects of desipramine DMI maintenance on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving.
NCT00000212 IV Cocaine Abuse: A Laboratory Model - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 1987-07-01 The purpose of this study is to evaluate the effects of desipramine DMI maintenance on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Desipramine Hydrochloride

Condition Name

Condition Name for Desipramine Hydrochloride
Intervention Trials
Depression 12
Substance-Related Disorders 6
Cocaine-Related Disorders 5
Schizophrenia 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Desipramine Hydrochloride
Intervention Trials
Depression 11
Depressive Disorder 9
Disease 6
Substance-Related Disorders 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Desipramine Hydrochloride

Trials by Country

Trials by Country for Desipramine Hydrochloride
Location Trials
United States 53
Canada 3
Switzerland 3
France 2
Austria 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Desipramine Hydrochloride
Location Trials
California 9
New York 7
Massachusetts 5
North Carolina 4
Missouri 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Desipramine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Desipramine Hydrochloride
Clinical Trial Phase Trials
Phase 4 13
Phase 3 8
Phase 2 18
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Desipramine Hydrochloride
Clinical Trial Phase Trials
Completed 45
Unknown status 5
Recruiting 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Desipramine Hydrochloride

Sponsor Name

Sponsor Name for Desipramine Hydrochloride
Sponsor Trials
National Institute on Drug Abuse (NIDA) 9
VA Office of Research and Development 7
Sandoz 4
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Desipramine Hydrochloride
Sponsor Trials
Other 60
NIH 18
Industry 17
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Dow
Moodys
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.